Benoît
is a global leader in medical aesthetics with a rare dual track record:
category-creating innovation and large-scale value creation.
Corporate
Value Creation
Filorga – Created the brand and led skincare
development; later acquired by Colgate-Palmolive for $1.4bn
CoolSculpting – Led international marketing;
category-defining body contouring platform acquired by Allergan for $2.5bn
Allurion – Scaled revenue as CCO from $3m to $65m,
leading to a $0.5bn NYSE IPO
Fastox – Board Member; contributed to acquisition by
AbbVie
Innovation
That Changed the Market
Restylane Skinboosters (15 years ago): shifted
injectables from volume to skin quality, creating an entirely new
treatment category
Sculptra Relaunch (10 years ago): repositioned
biostimulation as a long-term regenerative strategy, redefining
collagen-based aesthetics
Most
recently, Benoît has been appointed to the IMCAS Industry Innovation Jury, as
the main award of the IMCAS Innovation Tank and as Chairman of the AMWC
Catalyst, reinforcing his position as a leading authority on disruptive
innovation in medical aesthetics.
